WallStSmart
FRES

Fresh2 Group Ltd

NASDAQ: FRES · HEALTHCARE · DIAGNOSTICS & RESEARCH

$0.85
+0.00% today

Updated 2026-06-02

Market cap
$2.97M
P/E ratio
P/S ratio
0.12x
EPS (TTM)
$-72.68
Dividend yield
52W range
$0 – $0
Volume
0.3M

Fresh2 Group Ltd (FRES) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2019202020212022
Operating cash flow$-48.47M$-55.75M$-70.78M$-55.06M
Capital expenditures$3.15M$2.36M$3.92M$1.59M
Depreciation
Stock-based comp$226.41M$115.91M$217.50M$14.92M
Free cash flow$-51.62M$-58.10M$-74.70M$-56.65M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

What is Fresh2 Group Ltd's revenue?

Fresh2 Group Ltd's trailing twelve-month revenue is $16.98M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is FRES?

In its most recent fiscal year, FRES ran a gross margin of 69.21%, an operating margin of -870.20%, and a net margin of -846.01%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does FRES generate?

FRES produced $-56.65M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is FRES's balance sheet healthy?

FRES holds $1.87M in cash and equivalents against — in long-term debt, on $-13.68M of shareholder equity. That debt is best read against the cash flow the business throws off each year.